BakerHostetler Fights 'Indefensible' DQ In Opioid MDL
Law360 (May 8, 2019, 9:45 PM EDT) -- BakerHostetler on Wednesday asked the Sixth Circuit to vacate an Ohio judge's decision to disqualify the firm from representing Endo Pharmaceuticals in two bellwether cases in the multidistrict opioid litigation, saying the decision will affect the entire MDL.
The firm said that U.S. District Judge Dan Polster didn't base his decision on any record evidence, instead of relying exclusively on an unsworn letter from the U.S. Department of Justice that consists "entirely of hearsay." The letter, requested by the judge, said that that BakerHostetler partner Carole Rendon saw "nonpublic information" about the opioid crisis while she was serving at the U.S....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!